Investor's Business Daily on MSN11m
Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest MoneymakerNovartis stock rose Friday after the drugmaker beat fourth-quarter expectations, largely on the back of its heart failure drug Entresto.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback